Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07448558) titled 'Tailored Exercise to Reduce Aromatase Inhibitor Associated Musculoskeletal Symptoms' on Feb. 26.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Single (Outcomes Assessor).
Primary Sponsor: Mahidol University
Condition:
Patients With Early Breast Cancer Who Initiating Adjuvant Aromatase Inhibitor
Intervention:
Behavioral: tailored exercise
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: February 18, 2026
Target Sample Size: 206
Countries of Recruitment:
Thailand
To know more, visit http...